132 related articles for article (PubMed ID: 25111384)
1. Enhanced anti-tumor effect of zoledronic acid combined with temozolomide against human malignant glioma cell expressing O6-methylguanine DNA methyltransferase.
Fukai J; Koizumi F; Nakao N
PLoS One; 2014; 9(8):e104538. PubMed ID: 25111384
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity.
Horton TM; Jenkins G; Pati D; Zhang L; Dolan ME; Ribes-Zamora A; Bertuch AA; Blaney SM; Delaney SL; Hegde M; Berg SL
Mol Cancer Ther; 2009 Aug; 8(8):2232-42. PubMed ID: 19671751
[TBL] [Abstract][Full Text] [Related]
3. FoxM1-mediated RFC5 expression promotes temozolomide resistance.
Peng WX; Han X; Zhang CL; Ge L; Du FY; Jin J; Gong AH
Cell Biol Toxicol; 2017 Dec; 33(6):527-537. PubMed ID: 28185110
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms for hypoxia
Zhao H; Meng L; Liao X; Liu Y; Mo X; Gong M; Liao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):829-838. PubMed ID: 36039578
[TBL] [Abstract][Full Text] [Related]
5. New (alternative) temozolomide regimens for the treatment of glioma.
Wick W; Platten M; Weller M
Neuro Oncol; 2009 Feb; 11(1):69-79. PubMed ID: 18772354
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal-mitochondrial axis in zoledronic acid-induced apoptosis in human follicular lymphoma cells.
Mitrofan LM; Castells FB; Pelkonen J; Mönkkönen J
J Biol Chem; 2010 Jan; 285(3):1967-79. PubMed ID: 19875454
[TBL] [Abstract][Full Text] [Related]
7. A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas.
Lamb LS; Pereboeva L; Youngblood S; Gillespie GY; Nabors LB; Markert JM; Dasgupta A; Langford C; Spencer HT
Sci Rep; 2021 Oct; 11(1):21133. PubMed ID: 34702850
[TBL] [Abstract][Full Text] [Related]
8. Changes in pyruvate metabolism detected by magnetic resonance imaging are linked to DNA damage and serve as a sensor of temozolomide response in glioblastoma cells.
Park I; Mukherjee J; Ito M; Chaumeil MM; Jalbert LE; Gaensler K; Ronen SM; Nelson SJ; Pieper RO
Cancer Res; 2014 Dec; 74(23):7115-24. PubMed ID: 25320009
[TBL] [Abstract][Full Text] [Related]
9. Apigenin and Temozolomide Synergistically Inhibit Glioma Growth Through the
Wang D; Wang Z; Dai X; Zhang L; Li M
Cancer Biother Radiopharm; 2024 Mar; 39(2):125-132. PubMed ID: 33471569
[No Abstract] [Full Text] [Related]
10. p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acid.
Kuroda J; Kimura S; Segawa H; Sato K; Matsumoto S; Nogawa M; Yuasa T; Kobayashi Y; Yoshikawa T; Ottmann OG; Maekawa T
Cancer Sci; 2004 Feb; 95(2):186-92. PubMed ID: 14965371
[TBL] [Abstract][Full Text] [Related]
11. Folic acid-decorated astrocytes-derived exosomes enhanced the effect of temozolomide against glioma.
Liu HM; Zhang Y
Kaohsiung J Med Sci; 2024 May; 40(5):435-444. PubMed ID: 38482902
[TBL] [Abstract][Full Text] [Related]
12. Antitumor activity of zoledronic acid in primary breast cancer cells determined by the ATP tumor chemosensitivity assay.
Fehm T; Zwirner M; Wallwiener D; Seeger H; Neubauer H
BMC Cancer; 2012 Jul; 12():308. PubMed ID: 22824103
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition.
Chaplet M; Detry C; Deroanne C; Fisher LW; Castronovo V; Bellahcéne A
Biochem J; 2004 Dec; 384(Pt 3):591-8. PubMed ID: 15324309
[TBL] [Abstract][Full Text] [Related]
14. MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances response to temozolomide.
Bobustuc GC; Kassam AB; Rovin RA; Jeudy S; Smith JS; Isley B; Singh M; Paranjpe A; Srivenugopal KS; Konduri SD
Oncotarget; 2018 Jul; 9(51):29727-29742. PubMed ID: 30038716
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic selection through cell death: stochastic modelling of O-6-methylguanine-DNA methyltransferase dynamics.
Lasri A; Juric V; Verreault M; Bielle F; Idbaih A; Kel A; Murphy B; Sturrock M
R Soc Open Sci; 2020 Jul; 7(7):191243. PubMed ID: 32874597
[TBL] [Abstract][Full Text] [Related]
16. Protection against malignant progression of spontaneously developing liver tumors in transgenic mice expressing O(6)-methylguanine-DNA methyltransferase.
Qin X; Zhang S; Matsukuma S; Zarkovic M; Shimizu S; Ishikawa T; Nakatsuru Y
Jpn J Cancer Res; 2000 Nov; 91(11):1085-9. PubMed ID: 11092970
[TBL] [Abstract][Full Text] [Related]
17. UBE2C enhances temozolomide resistance by regulating the expression of p53 to induce aerobic glycolysis in glioma.
Zhou K; Wang D; Du X; Feng X; Zhu X; Wang C
Acta Biochim Biophys Sin (Shanghai); 2024 Apr; 56(6):916-926. PubMed ID: 38634120
[TBL] [Abstract][Full Text] [Related]
18. Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma.
Zhai Z; Samson JM; Yamauchi T; Vaddi PK; Matsumoto Y; Dinarello CA; Ravindran Menon D; Fujita M
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899791
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic microenvironment-induced exosomes confer temozolomide resistance in glioma through transfer of pyruvate kinase M2.
Li G; Xiong Z; Li Y; Yan C; Cheng Y; Wang Y; Li J; Dai Z; Zhang D; Du W; Men C; Shi C
Discov Oncol; 2024 Apr; 15(1):110. PubMed ID: 38598023
[TBL] [Abstract][Full Text] [Related]
20. Engineering Hyaluronic Acid Microneedles Loaded with Mn
Jiang Y; Jin Y; Feng C; Wu Y; Zhang W; Xiao L; Chu Z; Chen B; Ma Y; Qian H; Xu L
Adv Healthc Mater; 2024 Mar; 13(8):e2303215. PubMed ID: 38112062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
